Baum Hedlund is one of the leading national law firms representing Paxil suicide and suicide attempt victims across the country. The firm represents approximately 50 victims, over one third of those are children and adolescents.

Since 1990, Baum Hedlund has been handling antidepressant-SSRI (selective serotonin reuptake inhibitors) suicide/violence cases and served on the Plaintiffs' Steering Committee in the first SSRI-suicide litigation involving Prozac (the first SSRI approved by the FDA for marketing in the U.S.).

Baum Hedlund partner, Karen Barth Menzies, heads the firm's SSRI-Antidepressant Litigation Department and is Lead Counsel for the Plaintiffs' Steering Committee (MDL-1574) Paxil Products Liability Litigation.

Because of her proactive representation of Paxil suicide victims and their families, (testifying before state legislature and the FDA, meeting with members of the House and Senate, writing articles and giving speeches around the world regarding the risk of antidepressant induced suicide ) Drug Product Liability Attorney Karen Barth Menzies has received state and national Lawyer of the Year awards and a national 40 top lawyers under 40 award for her "extraordinary achievements" and "impressive track record" and for "stepping up her fight in the past few years, advocating that pharmaceutical companies should warn about the alleged risks of antidepressant drugs."